PAVMEDLOGONEW15OCT2018.png
PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update
15 nov. 2018 07h30 HE | PAVmed Inc.
Conference call to be held on November 15, 2018 at 4:30 p.m. Eastern time NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Hold Business Update Conference Call on November 15, 2018
01 nov. 2018 07h30 HE | PAVmed Inc.
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
23 oct. 2018 07h30 HE | PAVmed Inc.
NEW YORK, Oct, Oct. 23, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that...
PAVMEDLOGONEW15OCT2018.png
PAVmed Provides Business Update
17 oct. 2018 07h30 HE | PAVmed Inc.
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on...
PAVmed Reports Second Quarter 2018 Financial Results and Provides Business Update
14 août 2018 07h30 HE | PAVmed Inc.
Conference call to be held August 22, 2018 at 4:30 p.m. Eastern time NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVmed Inc. to Hold SECOND QUARTER FINANCIAL RESULTS AND BUSINESS UPDATE Conference Call on August 22, 2018
09 août 2018 07h30 HE | PAVmed Inc.
NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVmed Provides Business Update
25 juil. 2018 07h30 HE | PAVmed Inc.
 FDA confirms receipt of CarpX 510(k) resubmission for review NEW YORK, July 25, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...